Learn how to talk with patients who have major depressive disorder about antipsychotic treatment in a way that is clear and balanced and addresses patients’ potential concerns about taking antipsychotic medication.
Insights April 6, 2021
Talking With Patients Who Have Major Depressive Disorder About the Benefits and Risks Associated With Atypical Antipsychotics
J Clin Psychiatry 2020;81(3):OT19037BR3
Vol 86 • 2025 • Number 3
Read the Current Issue
Original Research
Postpartum Distress in Women With and Without ADHD
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Schizophrenia: A Consensus Panel Report
Academic Highlights
Clinical Application of Aripiprazole Monohydrate Long-Acting Injectables for the Treatment of Bipolar Type I Disorder: A Consensus Panel Report
In Memoriam
In Memoriam: Terence A. Ketter, MD
Narrative Review
Idiopathic Hypersomnia: Recognition and Management in Psychiatric Practice
Original Research
Predictors of Treatment Response to Adjunctive VNS Therapy in Major Depressive Disorder: A RECOVER Trial Report
Related Articles
Insights
Measurement-Based Care for Depressive Disorders: Meta-Analysis of RCTs Shows Efficacy
May 17, 2022
Dr Lam explains in this video how for patients with depressive disorders treated with pharmacotherapy, measurement-based care is effective in decreasing symptom severity, promoting remission, and improving medication adherence.
